Researchers say if their results are confirmed through further study they are optimistic the approach could be used to treat chronic infections for the first time.

Hepatocellular carcinoma continues to pose a diagnostic challenge, particularly in the setting of underlying pathomorphological changes in the liver due to cirrhosis, steatosis, or steatohepatitis.

A groundbreaking cancer study led by Professor Tom Bird from the Cancer Research UK Scotland Institute has discovered a drug ...

A new approach combining immunotherapy, radiation, and surgery enabled successful liver cancer removal in a high-risk patient ...